About SanuWave
SanuWave is a company based in Alpharetta (United States) founded in 2005. SanuWave has raised $1.43 million across 19 funding rounds from investors including CIT and Kingswood Photo Studio. The company has 46 employees as of December 31, 2024. SanuWave offers products and services including UltraMIST System and dermaPACE System. SanuWave operates in a competitive market with competitors including Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and Tempo Therapeutics, among others.
- Headquarter Alpharetta, United States
- Employees 46 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sanuwave Health, Inc.
-
Annual Revenue
$32.63 M (USD)59.99as on Dec 31, 2024
-
Net Profit
-$31.37 M (USD)-21.56as on Dec 31, 2024
-
EBITDA
$6.56 M (USD)1244.67as on Dec 31, 2024
-
Total Equity Funding
$1.43 M (USD)
in 19 rounds
-
Latest Funding Round
$1.8 M (USD), Post-IPO
Jun 18, 2024
-
Investors
CIT
& 1 more
-
Employee Count
46
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SanuWave
SanuWave is a publicly listed company on the NASDAQ with ticker symbol SNWV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SanuWave
SanuWave offers a comprehensive portfolio of products and services, including UltraMIST System and dermaPACE System.
FDA-cleared ultrasound system for faster wound healing via saline mist.
System to accelerate healing at the cellular level and reduce pain.
People of SanuWave
Unlock access to complete
Funding Insights of SanuWave
SanuWave has successfully raised a total of $1.43M across 19 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.8 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SanuWave
SanuWave has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include CIT and Kingswood Photo Studio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Photography services are offered for capturing life's memorable moments.
|
Locked | Locked | Locked | |
|
Provider of commercial equipment financing services
|
Locked | Locked | Locked |
Investor details for SanuWave
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SanuWave
Investment portfolio details for SanuWave
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SanuWave
Detailed financials for SanuWave
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sanuwave Comparisons
Peer comparison for SanuWave
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SanuWave
SanuWave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and Tempo Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| Locked | Locked | Locked |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| Locked | Locked | Locked |
Regenerative biomaterials for wounds are developed using particle technology.
|
Detailed competitors of SanuWave
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sanuwave
Complete news archive for SanuWave
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SanuWave
SanuWave was founded in 2005 and raised its 1st funding round 4 years after it was founded.
SanuWave is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
SanuWave is a funded company, having raised a total of $1.43M across 19 funding rounds to date.
As of Dec 31, 2024, the latest employee count at SanuWave is 46.
Annual revenue of SanuWave is $32.63M as on Dec 31, 2024.
Developer of Noninvasive devices, and biologics for wound healing. The products include the dermaPACE System an acoustic wave therapy for an advanced wound care, UltraMIST System an ultrasound therapy, orthoPACE system which utilizes PACE technology for the treatment of chronic pain caused by musculoskeletal disorders and inflammatory conditions. The biologics include Biovance and Interfyl for the treatment of damaged tissues.
SanuWave's top competitors include Ilya Pharma, QBiotics and Tempo Therapeutics.
SanuWave offers UltraMIST System and dermaPACE System.
Yes, SanuWave is publicly traded on NASDAQ under the ticker symbol SNWV.
SanuWave has 2 investors. Key investors include CIT, and Kingswood Photo Studio.
The ticker symbol of SanuWave is SNWV on NASDAQ.